subject area of

• A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010  Academic Article
• A method for the inclusion of physical activity-related health benefits in cost-benefit analysis of built environment initiatives  Academic Article
• Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Are weekend inpatient rehabilitation services value for money? An economic evaluation alongside a randomized controlled trial with a 30 day follow  Academic Article
• Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia  Academic Article
• Burden of disease and injury in Australia in the new millennium: Measuring health loss from diseases, injuries and risk factors  Academic Article
• Clinical effectiveness and cost-effectiveness of a multifaceted podiatry intervention for falls prevention in older people: a multicentre cohort randomised controlled trial (the REducing Falls with ORthoses and a Multifaceted podiatry intervention trial)  Academic Article
• Common values in assessing health outcomes from disease and injury: Disability weights measurement study for the Global Burden of Disease Study 2010  Academic Article
• Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trial  Academic Article
• Cost-Effectiveness Analysis of 3-D Computerized Tomography Colonography Versus Optical Colonoscopy for Imaging Symptomatic Gastroenterology Patients  Academic Article
• Cost-Effectiveness of Computed Tomographic Angiography Before Reoperative Coronary Artery Bypass Grafting  Academic Article
• Cost-Effectiveness of Coronary Computed Tomography and Cardiac Stress Imaging in the Emergency Department  Academic Article
• Cost-Effectiveness of a Home Based Intervention for Secondary Prevention of Readmission with Chronic Heart Disease  Academic Article
• Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort — The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care)  Academic Article
• Cost-effectiveness of investing in sidewalks as a means of increasing physical activity: a RESIDE modelling study  Academic Article
• Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: an early decision analytic model of multiplex targeted sequencing  Academic Article
• Cost-effectiveness of strain-targeted cardioprotection for prevention of chemotherapy-induced cardiotoxicity  Academic Article
• Decision analysis of tamoxifen for the prevention of invasive breast cancer  Academic Article
• Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010  Academic Article
• Economic evaluation of a dietary intervention for adults with major depression (the “SMILES” trial)  Academic Article
• Extrinsic Goals and Time Tradeoff  Academic Article
• Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015  Academic Article
• Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017  Academic Article
• Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition  Academic Article
• Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015  Academic Article
• Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017  Academic Article
• Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015  Academic Article
• Health economic evaluation  Academic Article
• Health outcomes are about choices and values: an economic perspective on the health outcomes movement  Academic Article
• Hepatitis C: an economic evaluation of extended treatment with interferon  Academic Article
• INFORMING DISINVESTMENT WITH LIMITED EVIDENCE: COBALAMIN DEFICIENCY IN THE FATIGUED  Academic Article
• Impartiality and Disability Discrimination  Academic Article
• Incorporating Biomarkers into the Primary Prostate Biopsy Setting: A Cost-Effectiveness Analysis  Academic Article
• Individualized Physical Therapy Is Cost-Effective Compared With Guideline-Based Advice for People With Low Back Disorders  Academic Article
• Is cost effectiveness sustained after weekend inpatient rehabilitation? 12 month follow up from a randomized controlled trial  Academic Article
• Long-term cost-effectiveness of home versus clinic-based management of chronic heart failure: the WHICH? study  Academic Article
• Management of Colorectal Cancer in Elderly Patients  Academic Article
• Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016  Academic Article
• Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015  Academic Article
• Morbidity, mortality and potential years of life lost attributable to smoking  Academic Article
• Multiple-informant ranking of the disabling effects of different health conditions in 14 countries  Academic Article
• Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: A cost-effectiveness analysis  Academic Article
• Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial  Academic Article
• Should programmes for community-level meningococcal vaccination be considered in Australia? An economic evaluation  Academic Article
• The Australian burden of disease study: Measuring the loss of health from diseases, injuries and risk factors  Academic Article
• The burden of disease and injury in Australia  Academic Article
• The cost-effectiveness of a law banning the use of cellular phones by drivers  Academic Article
• The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study  Academic Article
• To what extent is health and medical research funding associated with the burden of disease in Australia?  Academic Article
• Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010  Academic Article